Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2012

01.12.2012 | Epidemiology

Pattern of follow-up care and early relapse detection in breast cancer patients

verfasst von: Sandra M. E. Geurts, Femmie de Vegt, Sabine Siesling, Karin Flobbe, Katja K. H. Aben, Margriet van der Heiden-van der Loo, André L. M. Verbeek, Jos A. A. M. van Dijck, Vivianne C. G. Tjan-Heijnen

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Routine breast cancer follow-up aims at detecting second primary breast cancers and loco regional recurrences preclinically. We studied breast cancer follow-up practice and mode of relapse detection during the first 5 years of follow-up to determine the efficiency of the follow-up schedule. The Netherlands Cancer Registry provided data of 6,509 women, operated for invasive non-metastatic breast cancer in 2003–2004. In a random sample including 144 patients, adherence to follow-up guideline recommendations was studied. Mode of relapse detection was studied in 124 patients with a second primary breast cancer and 160 patients with a loco regional recurrence. On average 13 visits were performed during the first 5 years of the follow-up, whereas nine were recommended. With one, two and three medical disciplines involved, the number of visits was 9, 14 and 18, respectively. Seventy-five percent (93/124) of patients with a second primary breast cancer, 42 % (31/74) of patients with a loco regional recurrence after breast conserving surgery and 28 % (24/86) of patients with a loco regional recurrence after mastectomy had no symptoms at detection. To detect one loco regional recurrence or second primary breast cancer preclinically, 1,349 physical examinations versus 262 mammography and/or MRI tests were performed. Follow-up provided by only one discipline may decrease the number of unnecessary follow-up visits. Breast imaging plays a major and physical examination a minor role in the early detection of second primary breast cancers and loco regional recurrences. The yield of physical examination to detect relapses early is low and should therefore be minimised.
Literatur
1.
Zurück zum Zitat Kwaliteitsinstituut voor de Gezondheidszorg CBO, Nationaal Borstkanker Overleg NABON (2002) Richtlijn behandeling mammacarcinoom Kwaliteitsinstituut voor de Gezondheidszorg CBO, Nationaal Borstkanker Overleg NABON (2002) Richtlijn behandeling mammacarcinoom
2.
Zurück zum Zitat Lu WL, Jansen L, Post WJ, Bonnema J, van de Velde CJ, de Bock GH (2009) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 114:403–412PubMedCrossRef Lu WL, Jansen L, Post WJ, Bonnema J, van de Velde CJ, de Bock GH (2009) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 114:403–412PubMedCrossRef
3.
Zurück zum Zitat Houssami N, Ciatto S (2010) Mammographic surveillance in women with a personal history of breast cancer: how accurate? How effective? Breast 19:439–445PubMedCrossRef Houssami N, Ciatto S (2010) Mammographic surveillance in women with a personal history of breast cancer: how accurate? How effective? Breast 19:439–445PubMedCrossRef
4.
Zurück zum Zitat Palli D, Russo A, Saieva C, Ciatto S, Rosselli Del Turco M, Distante V, Pacini P (1999) Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA 281:1586PubMedCrossRef Palli D, Russo A, Saieva C, Ciatto S, Rosselli Del Turco M, Distante V, Pacini P (1999) Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA 281:1586PubMedCrossRef
5.
Zurück zum Zitat Lu W, Jansen L, Schaapveld M, Baas PC, Wiggers T, de Bock GH (2011) Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer? BMC Cancer 11:279PubMedCrossRef Lu W, Jansen L, Schaapveld M, Baas PC, Wiggers T, de Bock GH (2011) Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer? BMC Cancer 11:279PubMedCrossRef
6.
Zurück zum Zitat Grandjean I, Kwast AB, de Vries H, Klaase J, Schoevers WJ, Siesling S (2011) Evaluation of the adherence to follow-up care guidelines for women with breast cancer. Eur J Oncol Nurs 16(3):281–285PubMedCrossRef Grandjean I, Kwast AB, de Vries H, Klaase J, Schoevers WJ, Siesling S (2011) Evaluation of the adherence to follow-up care guidelines for women with breast cancer. Eur J Oncol Nurs 16(3):281–285PubMedCrossRef
7.
Zurück zum Zitat Grunfeld E, Hodgson DC, Del Giudice ME, Moineddin R (2010) Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract 6:174–181PubMedCrossRef Grunfeld E, Hodgson DC, Del Giudice ME, Moineddin R (2010) Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract 6:174–181PubMedCrossRef
8.
Zurück zum Zitat Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW (2009) Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol 20:1505–1510PubMedCrossRef Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW (2009) Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol 20:1505–1510PubMedCrossRef
9.
Zurück zum Zitat De Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ (2004) Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol 22:4010–4018PubMedCrossRef De Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ (2004) Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol 22:4010–4018PubMedCrossRef
10.
Zurück zum Zitat Lu W, de Bock GH, Schaapveld M, Baas PC, Wiggers T, Jansen L (2011) The value of routine physical examination in the follow up of women with a history of early breast cancer. Eur J Cancer 47:676–682PubMedCrossRef Lu W, de Bock GH, Schaapveld M, Baas PC, Wiggers T, Jansen L (2011) The value of routine physical examination in the follow up of women with a history of early breast cancer. Eur J Cancer 47:676–682PubMedCrossRef
11.
Zurück zum Zitat Blamey RW (2002) Estimation of prognosis of the individual with primary breast cancer and its applications. Scand J Surg 91:273–278PubMed Blamey RW (2002) Estimation of prognosis of the individual with primary breast cancer and its applications. Scand J Surg 91:273–278PubMed
13.
Zurück zum Zitat Kwaliteitsinstituut voor de Gezondheidszorg CBO, Nationaal Borstkanker Overleg NABON (2008) Mammacarcinoma Kwaliteitsinstituut voor de Gezondheidszorg CBO, Nationaal Borstkanker Overleg NABON (2008) Mammacarcinoma
14.
Zurück zum Zitat Cooper GS, Johnson CC, Lamerato L, Poisson LM, Schultz L, Simpkins J, Wells K, Yood MU, Chase G, Nathanson SD, Lafata JE (2006) Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications? Med Care 44:590–594PubMedCrossRef Cooper GS, Johnson CC, Lamerato L, Poisson LM, Schultz L, Simpkins J, Wells K, Yood MU, Chase G, Nathanson SD, Lafata JE (2006) Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications? Med Care 44:590–594PubMedCrossRef
15.
Zurück zum Zitat Ciatto S, Miccinesi G, Zappa M (2004) Prognostic impact of the early detection of metachronous contralateral breast cancer. Eur J Cancer 40:1496–1501PubMedCrossRef Ciatto S, Miccinesi G, Zappa M (2004) Prognostic impact of the early detection of metachronous contralateral breast cancer. Eur J Cancer 40:1496–1501PubMedCrossRef
16.
Zurück zum Zitat Montgomery DA, Krupa K, Jack WJ, Kerr GR, Kunkler IH, Thomas J, Dixon JM (2007) Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer 96:1802–1807PubMedCrossRef Montgomery DA, Krupa K, Jack WJ, Kerr GR, Kunkler IH, Thomas J, Dixon JM (2007) Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer 96:1802–1807PubMedCrossRef
17.
Zurück zum Zitat De Koning HJ, van Dongen JA, van der Maas PJ (1994) Changes in use of breast-conserving therapy in years 1978–2000. Br J Cancer 70:1165–1170PubMedCrossRef De Koning HJ, van Dongen JA, van der Maas PJ (1994) Changes in use of breast-conserving therapy in years 1978–2000. Br J Cancer 70:1165–1170PubMedCrossRef
18.
Zurück zum Zitat Voogd AC, van Beek MW, Crommelin MA, Kluck HM, Repelaer van Driel OJ, Coebergh JW (1994) Management of early breast cancer in southeast Netherlands since 1984. A population-based study. Regional Breast Cancer Study Group. Acta Oncol 33:753–757PubMedCrossRef Voogd AC, van Beek MW, Crommelin MA, Kluck HM, Repelaer van Driel OJ, Coebergh JW (1994) Management of early breast cancer in southeast Netherlands since 1984. A population-based study. Regional Breast Cancer Study Group. Acta Oncol 33:753–757PubMedCrossRef
19.
Zurück zum Zitat Ernst MF, Voogd AC, Coebergh J-WW, Poortmans PM, Roukema JA (2004) Using loco-regional recurrence as an indicator of the quality of breast cancer treatment. Eur J Cancer 40:487–493PubMedCrossRef Ernst MF, Voogd AC, Coebergh J-WW, Poortmans PM, Roukema JA (2004) Using loco-regional recurrence as an indicator of the quality of breast cancer treatment. Eur J Cancer 40:487–493PubMedCrossRef
20.
Zurück zum Zitat Van der Heiden-van-der Loo M, Ho VK, Damhuis RA, Siesling S, Menke MB, Peeters PH, Rutgers EJ (2010) Percentage of local recurrence following treatment for breast cancer is not a suitable performance indicator. Ned Tijdschr Geneeskd 154:A1984PubMed Van der Heiden-van-der Loo M, Ho VK, Damhuis RA, Siesling S, Menke MB, Peeters PH, Rutgers EJ (2010) Percentage of local recurrence following treatment for breast cancer is not a suitable performance indicator. Ned Tijdschr Geneeskd 154:A1984PubMed
21.
Zurück zum Zitat Montgomery DA, Krupa K, Cooke TG (2007) Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer 97:1632–1641PubMedCrossRef Montgomery DA, Krupa K, Cooke TG (2007) Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer 97:1632–1641PubMedCrossRef
22.
Zurück zum Zitat Kwaliteitsinstituut voor de Gezondheidszorg CBO Nationaal Borstkanker Overleg NABON (2012) Mammacarcinoom Kwaliteitsinstituut voor de Gezondheidszorg CBO Nationaal Borstkanker Overleg NABON (2012) Mammacarcinoom
23.
Zurück zum Zitat Van Hezewijk M, Ranke GMC, van Nes JGH, Stiggelbout AM, de Bock GH, van de Velde CJ (2011) Patients’ needs and preferences in routine follow-up for early breast cancer; an evaluation of the changing role of the nurse practitioner. Eur J Surg Oncol 37:765–773PubMedCrossRef Van Hezewijk M, Ranke GMC, van Nes JGH, Stiggelbout AM, de Bock GH, van de Velde CJ (2011) Patients’ needs and preferences in routine follow-up for early breast cancer; an evaluation of the changing role of the nurse practitioner. Eur J Surg Oncol 37:765–773PubMedCrossRef
24.
Zurück zum Zitat Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C, Palmer N, Ream E, Young A, Richardson A (2009) Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol 27:6172–6179PubMedCrossRef Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C, Palmer N, Ream E, Young A, Richardson A (2009) Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol 27:6172–6179PubMedCrossRef
25.
Zurück zum Zitat Kimman ML, Dirksen CD, Voogd AC, Falger P, Gijsen BC, Thuring M, Lenssen A, van der Ent F, Verkeyn J, Haekens C, Hupperets P, Nuytinck JK, van Riet Y, Brenninkmeijer SJ, Scheijmans LJ, Kessels A, Lambin P, Boersma LJ (2011) Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2 × 2 randomised controlled trial. Eur J Cancer 47:1027–1036PubMedCrossRef Kimman ML, Dirksen CD, Voogd AC, Falger P, Gijsen BC, Thuring M, Lenssen A, van der Ent F, Verkeyn J, Haekens C, Hupperets P, Nuytinck JK, van Riet Y, Brenninkmeijer SJ, Scheijmans LJ, Kessels A, Lambin P, Boersma LJ (2011) Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2 × 2 randomised controlled trial. Eur J Cancer 47:1027–1036PubMedCrossRef
26.
Zurück zum Zitat Grunfeld E, Fitzpatrick R, Mant D, Yudkin P, Adewuyi-Dalton R, Stewart J, Cole D, Vessey M (1999) Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 49:705–710PubMed Grunfeld E, Fitzpatrick R, Mant D, Yudkin P, Adewuyi-Dalton R, Stewart J, Cole D, Vessey M (1999) Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 49:705–710PubMed
27.
Zurück zum Zitat Sheppard C, Higgins B, Wise M, Yiangou C, Dubois D, Kilburn S (2009) Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs 13:2–8PubMedCrossRef Sheppard C, Higgins B, Wise M, Yiangou C, Dubois D, Kilburn S (2009) Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs 13:2–8PubMedCrossRef
28.
Zurück zum Zitat Brodersen J, Jørgensen KJ, Gøtzsche PC (2010) The benefits and harms of screening for cancer with a focus on breast screening. Pol Arch Med Wewn 120:89–94PubMed Brodersen J, Jørgensen KJ, Gøtzsche PC (2010) The benefits and harms of screening for cancer with a focus on breast screening. Pol Arch Med Wewn 120:89–94PubMed
29.
Zurück zum Zitat Health Council of the Netherlands (2007) Follow-up in oncology: identify objectives, substantiate actions. Report No. 2007/10. The Hague: Health Council of the Netherlands Health Council of the Netherlands (2007) Follow-up in oncology: identify objectives, substantiate actions. Report No. 2007/10. The Hague: Health Council of the Netherlands
Metadaten
Titel
Pattern of follow-up care and early relapse detection in breast cancer patients
verfasst von
Sandra M. E. Geurts
Femmie de Vegt
Sabine Siesling
Karin Flobbe
Katja K. H. Aben
Margriet van der Heiden-van der Loo
André L. M. Verbeek
Jos A. A. M. van Dijck
Vivianne C. G. Tjan-Heijnen
Publikationsdatum
01.12.2012
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2012
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-012-2297-9

Weitere Artikel der Ausgabe 3/2012

Breast Cancer Research and Treatment 3/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.